Target intelligence / Profile preview

Mucin-2 (MUC2)

Target
MUC2
Molecular classification
Glycoprotein, Gel-forming mucin, Extracellular matrix protein
01

Overview

Mucin-2 (MUC2) is a large gel-forming mucin and highly glycosylated protein produced by goblet cells of the intestinal tract. It is the primary constituent of the mucus layer that protects and lubricates the gastrointestinal epithelium, forming a physical and chemical barrier that separates the intestinal microbiota from the underlying tissues and immune system. The structure of MUC2 features a protein core of over 5000 amino acids, characterized by extensive tandem PTS (proline, threonine, serine-rich) repeats and a highly glycosylated central domain. The C-terminal end forms dimers through cystine-knot domains and additional disulfide bonds, contributing to stable mucus network formation. Besides its mechanical and protective role, MUC2 participates in regulating copper homeostasis and acts as a scaffold for antimicrobial molecules. Altered MUC2 function or expression is implicated in diseases such as inflammatory bowel disease and colorectal cancer, but it is not currently a direct drug target.

Other names
Intestinal mucin-2MUC-2SMUC
02

Mechanism of action

Not applicable; Mucin-2 is not directly targeted by drugs, functions as a physical barrier rather than a drug-mediated target

03

Biological functions

Formation of mucus gel barrierMaintenance of epithelial integrityRegulation of intestinal microbiota compositionHost defense (innate immunity)Lubrication of mucosal surfacesDetoxification of copper ion
04

Disease associations

Inflammatory bowel diseases (e.g., ulcerative colitis)Colorectal cancerInfection susceptibility (through barrier dysfunction)Other gastrointestinal disorders (e.g., goblet cell dysfunction)
05

Safety considerations

Challenges in therapeutic modulation due to essential barrier functionDeficiency or dysfunction leads to increased susceptibility to infection and inflammation
06

Biomarkers

Reduced/altered MUC2 expression or structure may be used as a biomarker for inflammatory bowel disease, colorectal cancer, or mucosal barrier integrity

Beyond the preview

Go deeper on Mucin-2 (MUC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mucin-2 (MUC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call